Neil Bodick bought FLXN once, on Nov 21, 2017
Chief Scientific Officer at Horizon Flexible Income ETF
SEC CIK 0001598099 · Filings on SEC.gov ↗
$66KBought
$2.0MSold
Nov 22Last buy
Neil Bodick's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
8 filings since Dec 2016, newest first
FLXNSell
Flexion Therapeutics Inc
Chief Scientific Officer
$1.3M−10.0%Jul 3
FLXNBuy
Flexion Therapeutics Inc
Chief Scientific Officer
$66K+1.0%Nov 22
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$129K−1.0%May 19
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$141K−1.0%May 19
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$102K−1.0%May 19
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$96K−1.0%May 19
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$92K−1.0%Jan 23
FLXNSell
Flexion Therapeutics Inc
Chief Medical Officer
$185K−2.0%Dec 22
Filings come from SEC EDGAR. Not investment advice.